共 50 条
[1]
Cerfolio R.J., Bryant A.S., Ohja B., Bartolucci A.A., The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival, J Thorac Cardiovasc Surg, 130, pp. 151-159, (2005)
[2]
Cerfolio R.J., Bryant A.S., Ojha B., Eloubeidi M., Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial, Ann Thorac Surg, 80, pp. 1207-1214, (2005)
[3]
Subedi N., Scarsbrook A., Darby M., Korde K., Mc Shane P., Muers M.F., The clinical impact of integrated FDG PET–CT on management decisions in patients with lung cancer, Lung Cancer, 64, 3, pp. 301-307, (2009)
[4]
Dijkman B., Schuurbiers O., Vriens D., Looijen-Salamon M., Bussink J., Timmer-Bonte J., Snoeren M., Oyen W., van der Heijden H., de Geus-Oei L.-F., The role of 18F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours, Eur J Nucl Med Mol Imaging, 37, 11, pp. 2037-2047, (2010)
[5]
Gregory D.L., Hicks R.J., Hogg A., Binns D.S., Shum P.L., Milner A., Link E., Ball D.L., Mac Manus M.P., Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data, J Nucl Med, 53, 7, pp. 1007-1015, (2012)
[6]
Erdi Y.E., Macapinlac H., Rosenzweig K.E., Humm J.L., Larson S.M., Erdi A.K., Yorke E.D., Use of PET to monitor the response of lung cancer to radiation treatment, Eur J Nucl Med Mol Imaging, 27, 7, pp. 861-866, (2000)
[7]
Beyer T., Czernin J., Freudenberg L.S., Variations in clinical PET/CT operations: results of an international survey of active PET/CT users, J Nucl Med, 52, 2, pp. 303-310, (2011)
[8]
Bryant A.S., Cerfolio R.J., The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules, Ann Thorac Surg, 82, 3, pp. 1016-1020, (2006)
[9]
Nambu A., Kato S., Sato Y., Okuwaki H., Nishikawa K., Saito A., Matsumoto K., Ichikawa T., Araki T., Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET, Ann Nucl Med, 23, 3, pp. 269-275, (2009)
[10]
Young H., Baum R., Cremerius U., Herholz K., Hoekstra O., Lammertsma A.A., Pruim J., Price P., Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group, Eur J Cancer, 35, pp. 1773-1782, (1999)